Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |